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Abstract
Congenital disorders (often also called birth defects) are an important cause of mortality and disability. They encompass a wide
range of disorders with differing severity that can affect any aspect of structure or function. Understanding their epidemiology is
important in developing appropriate services both for their prevention and treatment. The need for epidemiological data on
congenital disorders has been recognised for many decades. Here, we provide a historical overview of work that has led to the
development of the Modell Global Database of Congenital Disorders (MGDb)—a tool that can be used to generate evidence-
based country, regional and global estimates of the birth prevalence and outcomes of congenital disorders.
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Historical background
Congenital disorders (often also called birth defects) are an
important cause of mortality and disability. They encompass
a wide range of disorders with differing severity that can affect
any aspect of structure or function. The need for epidemiolog-
ical data on congenital disorders was recognised in the after-
math of the Second World War, when the United Nations
Scientific Committee on the Effects of Atomic Radiation
(UNSCEAR) was established Bto collect and evaluate infor-
mation on the levels and effects of exposure to ionizing
radiation^ (United Nations Scientific Committee on the
Effects of Atomic Radiation 1977; United Nations Scientific
Committee on the Effects of Atomic Radiation 1982; United
Nations Scientific Committee on the Effects of Atomic
Radiation 1986). Accordingly, meticulous controlled studies
on the prevalence of congenital disorders in the populations of
Hiroshima and Nagasaki were conducted on the assumption
that an increased mutation rate would manifest as an increased
birth prevalence of affected children (Schull 1958; Schull
2003; Schull et al. 1981).
At the same time, a combination of increasing technical
diagnostic ability, the observed effects of rubella infection,
and the thalidomide disaster of the 1960s led to increased
recognition of the contribution of congenital disorders to early
death and disability, the potential power of interventions and
the need for ongoing surveillance. Accordingly, the World
Health Organization encouraged epidemiological studies, the
development of congenital anomaly registries and the con-
struction of databases for common genetically determined dis-
orders. The importance of surveillance was further reinforced
by the thalidomide disaster in the 1960s.
Congenital anomaly registries
Congenital anomaly registries were progressively established
from the 1950s onwards. Two of the earliest registries have
made unique contributions to global epidemiology. The first is
the British Columbia Health Surveillance Registry, which was
initiated in 1952 (Baird 1987). Whilst most congenital anom-
aly registries include only severe disorders associated with
structural change, i.e. the Bcongenital malformations, defor-
mations and chromosomal disorders^ included in chapter
XV11 of ICD10 (World Health Organization 1992), this reg-
istry also included single-gene disorders. The reported birth
prevalences of rare single-gene disorders from this registry are
This is part of the SI on Methods in Community Genetics
* Matthew W Darlison
m.darlison@ucl.ac.uk
1 WHO Collaborating Centre for Community Genetics, Centre for
Health Informatics and Multiprofessional Education (CHIME),
University College London, London, UK
2 London School of Hygiene & Tropical Medicine, London, UK
Journal of Community Genetics
https://doi.org/10.1007/s12687-018-0382-4
relevant today, and provide the input data used in the Modell
Global Database of Congenital Disorders (MGDb) (Blencowe
et al. 2018; Modell et al. 2016). The second, the national
Hungarian Congenital Abnormality Registry, initiated in
1962 (Czeizel 1997) was exceptional because it was partnered
with a public health initiative, the Hungarian Optimal
Planning Programme (Czeizel 2012; Czeizel et al. 1998).
This combination enabled many invaluable studies, including
a pioneering assessment of the burden of congenital anomalies
in terms of years of life lost, lived with disability or lived
effectively cured (Czeizel and Sankaranarayanan 1984), esti-
mates of the power of interventions for prevention and care
(Czeizel et al. 1993), and randomised controlled trials of in-
terventions aiming to improve birth outcomes, including
preconceptional supplementation with multivitamins
(Czeizel and Dudas 1992) or folic acid (Czeizel et al. 1996).
Particularly important from the point of view of global
epidemiology, two Bumbrella registries^ were initiated in
1974 to collect, standardise and harmonise birth prevalence
data from individual registries and regularly publish key ref-
erence data (Moorthie et al. 2017b). The European
Surveillance of Congenital Anomalies and Twins network
(EUROCAT, www.eurocat-network.eu) aims to record the
majority of severe congenital anomalies. The International
Clearing House for Birth Defect Surveillance and Research
(ICBDSR, www.icbdsr.org) collects data from countries at
all levels of development, and so reports on the
approximately 30% of congenital anomalies that can be
reliably diagnosed around the time of birth in the absence of
advanced facilities. These umbrella registries have the
outstanding advantage that (when possible) they report all
birth outcomes (termination of pregnancy for fetal
impairment, fetal death/stillbirth, live birth), and so enable
quantification of the effect of interventions that affect birth
prevalence or birth outcomes.
Databases of genetically determined disorders
Key additional resources are three databases on genetic deter-
minants of disorders whose birth prevalence differs between
populations—ABO and rhesus blood groups (Mourant et al.
1976), haemoglobin disorders and G6PD deficiency
(Livingstone 1985) and prevalence of parental consanguinity
(Bittles and Black 2015).
Classical epidemiological studies
Table 1 shows classical epidemiological studies that have ex-
amined the birth prevalence of congenital disorders. These
studies also have the advantage that they predate the introduc-
tion of interventions that reduce affected birth prevalence (e.g.
periconceptional vitamin supplementation, termination of
pregnancy for fetal impairment), or increase detection rates
(e.g. routine fetal anomaly scanning, sophisticated neonatal
screening). Although the range of diagnoses included differed
between studies, and most studies were conducted in popula-
tions of European origin, the rates observed were broadly
consistent, and were generally considered to apply worldwide
(Baird et al. 1988).
AC Stevenson was the first to attempt to measure Bthe load
of hereditary defects in human populations^, based on the
number and age distribution of patients referred to his
Northern Ireland clinic (Stevenson 1959). This study includes
valuable estimates of birth prevalence and early mortality at a
time when only supportive care was available. It led theWHO
to conduct a comparative study of the birth prevalence of
selected congenital anomalies in 24 centres representing all
WHO regions, to review the global prevalence and manage-
ment of haemoglobin disorders and to publish three technical
reports (Stevenson et al. 1966; World Health Organization
1966; World Health Organization 1972).
Towards development of a global
epidemiological picture
In the early 1980s, Anver Kuliev, then director of the WHO
Hereditary Diseases Programme, reviewed the available data
and identified the three key elements of Community
Genetics—epidemiology, audit of the effect of interventions
(surveillance) and information and education (World Health
Organization 1985). Accordingly, he initiated development of
a global epidemiological picture, starting with country-specific
estimates for the haemoglobin disorders (Modell and Darlison
2008). The work was continued with support from the
Wellcome Trust and the WHO Office for the Eastern
Mediterranean Region (Alwan et al. 1997; Christianson and
Modell 2004; Modell 1992). The resulting estimates contribut-
ed to several WHO reports (World Health Organization 2000;
World Health Organization and March of Dimes 2006), pro-
vided the quantitative basis for the influential March of Dimes
Global Report on Birth Defects (Christianson et al. 2006) and
contributed baseline estimates for the BBorn Healthy^(http://
www.bornhealthy.org) Needs Assessment Toolkit (Nacul
et al. 2014). WHO endorsement of the March of Dimes esti-
mates led in turn to inclusion of congenital disorders in the
Global Burden of Disease study (Lopez et al. 2006), and a
Resolution on Birth Defects by the World Health Assembly
(World Health Organization and 2010).
The Executive Board’s first recommendation to the World
Health Assembly was Bto promote the collection of data on
the global burden of mortality and morbidity due to birth
defects^, and the resolution included the recommendation to
Bresolve currently divergent opinions on the health burden of
both environmental and constitutional birth defects^. We
therefore formed an informal international expert group to
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develop and review methods for estimating birth prevalence
and outcomes of congenital disorders, compliant with the rec-
ommendations of the Guidelines for Accurate and Transparent
Health Estimates Reporting (GATHER) Working Group
(Stevens et al. 2016).
The Modell Global Database of Congenital Disorders
Congenital disorders can be divided into five groups: environ-
mental disorders (due tomaternal exposure to, e.g. infection or
other hazards), chromosomal disorders, congenital
malformations, single-gene disorders and disorders due to
common genetic risk factors (Fig. 1). In the absence of
intervention, the birth prevalence of four of these groups is
largely determined by endogenous causes, so is relatively con-
stant for any given population, and may be called their base-
line birth prevalence. Sufficient data is available to obtain
country-specific estimates of baseline birth prevalence for
these four disorder groups (Modell et al. 2016; Moorthie
et al. 2017a).
The availability of a baseline birth prevalence is an unusu-
al, possibly unique, characteristic. It offers exceptional advan-
tages from an epidemiological point of view because once it is
known, it can be related to available demographic and survival
data and the observed effects of interventions, to reach
country-specific estimates of the distribution of actual out-
comes, including termination of pregnancy, fetal death,
under-five death, disability and cure. Furthermore, the sum
of outcomes must fill the original Benvelope^ of baseline birth
prevalence. That is, these disorder groups can be handled as
closed systems. In view of this important characteristic, these
four groups are here collectively called constitutional congen-
ital disorders.
The MGDb exploits this exceptional characteristic to gen-
erate evidence-based country, regional and global estimates of
the birth prevalence and outcomes of constitutional congenital
disorders that can be used as a starting point for service
planning.
Currently, MGDb does not include congenital disorders
caused by environmental risk factors such as maternal infec-
tion, malnutrition or exposure to teratogens. This is not to
detract from the relevance of Benvironmental^ congenital dis-
orders. They have high priority because they can be largely
prevented by basic public health interventions including san-
itation, immunisation, nutritional supplementation, restriction
of exposure to teratogens and diagnosis and treatment for the
mother before or during pregnancy, and so occupy an impor-
tant position in WHO recommendations for pregnancy care
(World Health Organisation 2013). They are not currently
Fig. 1 The main groups of congenital disorders. The image is notional:
there is no relation between frequency and the size of the circles, or actual
extent of overlap between categories. MGDb currently includes only the
groups whose birth prevalence is relatively constant or can be calculated,
namely chromosomal disorders, early-onset congenital malformations,
single-gene disorders and two examples of common early-onset
disorders due to genetic risk factors—rhesus haemolytic disease and
neonatal jaundice due to glucose-6-phosphate dehydrogenase deficiency.
Table 1 Classical studies of the
birth prevalence of congenital
disorders
Source Chromosomal
disorders
Congenital
malformations
Rare single-gene
disorders
Neel (1958) +
Stevenson (1959) + + +
Stevenson et al. (1966) +
Trimble and Doughty (1974) + + +
Myrianthopoulos and Chung
(1974)
+
Ash et al. (1977) + + +
Hook and Hamerton (1977) +
Carter (1977) +
Czeizel and Sankaranarayanan
(1984)
+ +
All studies include only disorders that cause death or disability in the absence of intervention
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included in MGDb because their baseline birth prevalence is
determined by exposure to risk and so varies with place, time
and deployment of interventions. Ongoing surveillance or pe-
riodic surveys are required to follow their epidemiology but
resources for surveillance are most limited in the countries
where they are most prevalent. Therefore, insufficient
country- and time-specific observational data are available to
permit the form of modelling used in MGDb. Should suffi-
cient data become available, they might be included in the
future.
In buildingMGDb, we developed a subset of epidemiolog-
ical methods specific to congenital disorders that are simple
enough for use by non-specialist health professionals. The
articles in this special issue of the Journal of Community
Genetics provide an introduction to these methods. Of equal
importance, we encountered many examples of ill-defined or
ambiguous terminology, so that it was necessary to establish
precise definitions of all terms used. Selected country-specific
outputs, a full description of the methods and the terminology
used are available online at http://discovery.ucl.ac.uk/
1532179/ (Modell et al. 2016).
Other sources of data on epidemiology
of congenital disorders
The Global Burden of Disease (GBD) study has also pub-
lished country-specific estimates of mortality and disability
due to congenital anomalies, haemoglobin disorders and
G6PD deficiency. The methods used by GBD differ from
those used in MGDb and this leads to wide differences be-
tween the estimates. For example, the omission by GBD of
stillbirths and terminations of pregnancy for fetal impairment
leads to serious underestimation of the burden of congenital
anomalies in high-income settings (Boyle et al. 2017), whilst
the lack of accurate cause of death data in low- and middle-
income countries leads to serious underestimation of early
mortality due to congenital anomalies by the GBD (Boyle
et al. 2017; Moorthie et al. 2017a). In addition, the fact that
estimates for early-onset single-gene disorders, rhesus
haemolytic disease and kernicterus due to G6PD deficiency
are included in MGDb but not in the GBD widens the osten-
sible difference between the estimates.
Conclusions Congenital disorders continue to be important
contributors to mortality and disability. The need for epidemi-
ological data in this field has been recognised for decades.
Policy and service development are reliant on such data to
assess the burden of disease and the impact of interventions.
Efforts such as the establishment of registries and research
studies help to generate evidence to support policy, but there
is still a lack data from low- and middle-income countries.
Simple methods that enable policymakers to make up for this
deficiency are needed as a starting point.
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